Does the patient know best? Quality of life assessment in multiple sclerosis trials

Gold R Kappos L Arnold DL . Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis. N Engl J Med 2012; 367: 1098–1107.

Fox RJ Miller DH Phillips JT . Placebo-controlled Phase 3 study of oral BG-12 or glatiramer in multiple sclerosis. N Engl J Med 2012; 367: 1087–1097.

Kappos L Gold R Arnold D L . Quality of life outcomes with BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis in the DEFINE study. Mult Scler

Mitchell AJ Benito-Leon J Morales Gonzalez J-M . Quality of life and its assessment in multiple sclerosis: Integrating physical and psychological components of wellbeing. Lancet Neurology 2005; 4: 556–566.

Kita M Fox RJ Phillips JT . Effects of BG-12 (dimethyl fumarate) on health-related quality of life in patients with relapsing–remitting multiple sclerosis: Findings from the CONFIRM study. Mult Scler

European Medicines Agency. Guideline on clinical investigation of medicinal products for the treatment of multiple sclerosis. Draft 20 September 2012 EMA/CHMP/771815/2011, Rev 2, Committee for Medicinal Products for Human Use (CHMP). 2012. (Accessed 08 November 2013 at http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2012/10/WC500133438.pdf.)

Riazi A Hobart JC Lamping DL . Evidence-based measurement in multiple sclerosis: The psychometric properties of the physical and psychological dimensions of three quality of life rating scales. Mult Scler 2003; 9: 411–419.

Cella D Lai J-S Nowinski CJ . Neuro-QOL. Brief measures of health-related quality of life for clinical research in neurology. Neurology 2012; 78: 1860–1867.

Schwartz CE Sprangers MAG . Methodological approaches for assessing response shift in longitudinal health-related quality-of-life research. Soc Sci Med 1999; 48: 1531–1548.

La Mantia L Eoli M Salmaggi A . Does a placebo effect exist in clinical trials in multiple sclerosis? Ital J Neurol Sci 1996; 17: 135–139.

Hoogervorst ELJ Eikelenboom MJ Uitdehaag BMJ . One year changes in disability in multiple sclerosis: Neurological examination compared with patient self report. J Neurol Neurosurg Psychiatry 2003; 74: 439–442.

Coenen M Cieza A Freeman J . The development of the ICF Core Sets for multiple sclerosis: results of the International Consensus Conference. J Neurol 2011; 258: 1477–1488.